1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. HIV and AIDS

Ibalizumab for treating adults infected with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2720]

Awaiting development [GID-TA10657] Expected publication date: TBC

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators  
  • Draft scope pre referral PDF 167 KB 17 June 2020  
  • Draft matrix pre referral PDF 187 KB 17 June 2020